Medline Growth Metrics (2025-2026)

Reported Financials

Medline Quarterly Growth Metrics

Periods 6 quarters

Latest Sep 2026

Medline reported revenue growth of 10.41% for the quarter ended Sep 2026. These growth metrics cover 6 quarters of results from Jun 2025 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026	Sep2026
Growth Ratios
Total Debt (QoQ)				0.09%	0.04%	0.02%
Total Debt Growth (1y)			-23.85%
Tax Rate (QoQ)	251.00	-58.00	595.00	525.00	0.00M	0.00M
Tax Rate Growth (1y)				0.00M	0.00M	0.00M
Share-based Compensation (QoQ)Stock Comp. (QoQ)	-21.05%	0.00%	80.00%	-14.81%	26.09%	0.00%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)				21.05%	93.33%	93.33%
Revenue (QoQ)	3.64%	3.33%	9.44%	-5.59%	4.53%	2.23%
Revenue Growth (1y)				10.66%	11.60%	10.41%
Return on Sales [ROS] (QoQ)ROS (QoQ)	73.00	-126.00	-261.00	28.00	-60.00	122.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y)				-285.00	-418.00	-170.00
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ)					-112.00	-38.00
Return on Equity [ROE] (QoQ)ROE (QoQ)					-98.00	-3.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)					-72.00	-22.00
Return on Assets [ROA] (QoQ)ROA (QoQ)					-53.00	-4.00
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)				-0.42%	-1.28%	0.66%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)			3.98%
Operating Margin (QoQ)	73.00	-126.00	-261.00	28.00	-60.00	122.00
Operating Margin Growth (1y)				-285.00	-418.00	-170.00
Operating Income (QoQ)Op. Inc (QoQ)	12.43%	-10.59%	-25.96%	-0.71%	-6.40%	26.58%
Operating Income Growth (1y)Op. Inc Growth (1y)				-26.09%	-38.47%	-12.89%
Net Margin (QoQ)	-2.00	-31.00	-199.00	58.00	-173.00	276.00
Net Margin Growth (1y)				-174.00	-345.00	-38.00
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)	3.13%	-3.34%	-39.31%	16.58%	-54.67%	214.71%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)				-29.47%	-69.00%	0.94%
Net Income (QoQ)	3.13%	-3.34%	-39.31%	23.83%	-41.84%	128.78%
Net Income Growth (1y)				-25.08%	-57.75%	0.00%
Net Cash Flow (QoQ)NCF (QoQ)	-147.16%	236.50%	164.17%	-69.33%	-68.65%	-103.16%
Net Cash Flow Growth (1y)NCF Growth (1y)				-47.85%	134.67%	-100.80%
Income After Tax (QoQ)	3.42%	-3.30%	-44.10%	32.78%	-41.84%	128.78%
Income After Tax Growth (1y)				-25.78%	-58.26%	-1.24%
Gross Profit (QoQ)	4.44%	-1.57%	2.08%	-3.81%	20.32%	-13.09%
Gross Profit Growth (1y)				0.93%	16.27%	2.67%
Gross Margin (QoQ)	21.00	-131.00	-177.00	46.00	378.00	-432.00
Gross Margin Growth (1y)				-241.00	116.00	-185.00
Free Cash Flow (QoQ)FCF (QoQ)	-85.10%	514.94%	-82.99%	247.25%	91.14%	46.36%
Free Cash Flow Growth (1y)FCF Growth (1y)				-45.89%	594.25%	65.23%
FCF Payout Ratio (QoQ)FCF Cover (QoQ)			374.28%
FCF Margin (QoQ)	-753.00	626.00	-635.00	313.00	356.00	339.00
FCF Margin Growth (1y)				-449.00	660.00	373.00
EPS (Diluted) (QoQ)				14.46%	-56.56%	105.83%
EPS (Basic) (QoQ)	3.13%	-3.34%	-100.00%	15.29%	-56.67%	207.72%
EPS (Basic) Growth (1y)				-100.00%	-100.00%	-100.00%
EBT (QoQ)	6.21%	-3.90%	-40.29%	41.26%	-19.24%	64.26%
EBT Margin (QoQ)	13.00	-36.00	-220.00	131.00	-90.00	186.00
EBT Margin Growth (1y)				-113.00	-216.00	6.00
EBT Growth (1y)				-13.91%	-34.54%	11.88%
EBIT (QoQ)	12.43%	-10.59%	-25.96%	-0.71%	-6.40%	26.58%
EBIT Margin (QoQ)	73.00	-126.00	-261.00	28.00	-60.00	122.00
EBIT Margin Growth (1y)				-285.00	-418.00	-170.00
EBIT Growth (1y)				-26.09%	-38.47%	-12.89%
EBITDA Margin (QoQ)	63.00	-134.00	-284.00	36.00	-70.00	115.00
EBITDA Margin Growth (1y)				-319.00	-453.00	-205.00
Dividends Paid - Common (QoQ)Div. Paid (Common) (QoQ)			-19.33%
Dividend Coverage Ratio (QoQ)Div. Cover (QoQ)			-24.77%
Cash from Operations (QoQ)Cash from Ops. (QoQ)	-71.11%	222.84%	-63.99%	79.91%	73.54%	43.36%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)				-39.59%	262.94%	61.16%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)	-55.43%	29.37%	-36.63%	30.43%	-380.21%	-112.58%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)				-4.35%	-222.38%	-870.30%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)				15.32%	4.07%	-0.26%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)			874.37%
Capital Expenditures (QoQ)Capex (QoQ)	12.24%	-8.18%	36.63%	-30.43%	15.63%	27.03%
Capital Expenditures Growth (1y)Capex Growth (1y)				-2.04%	0.91%	39.60%
Assets (QoQ)				1.38%	0.86%	2.10%
Assets Growth (1y)			6.97%

Medline Growth Metrics API

Pull Medline's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MDLN&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "MDLN", "statement": "Growth", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=MDLN&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Medline MDLN Growth Metrics (2025-2026)

Medline Quarterly Growth Metrics

Medline Growth Metrics API

Create an account

Sign In

Reset Password